Literature DB >> 10388257

Are sociodemographic factors important in sarcoidosis?

R C Young1.   

Abstract

Entities:  

Mesh：

Year:  1999        PMID： 10388257      PMCID： PMC2608498     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


× No keyword cloud information.
  9 in total

1.  Sarcoidosis among children. A review.

Authors:  E L KENDIG
Journal:  J Pediatr       Date:  1962-08       Impact factor: 4.406

2.  Reduced prevalence of smokers in sarcoidosis. Results of a case-control study.

Authors:  R A Harf; C Ethevenaux; J Gleize; M Perrin-Fayolle; J C Guerin; C Ollagnier
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

3.  Epidemiology of sarcoidosis: ethnic and geographic considerations.

Authors:  R C Young; R L Hackney; K A Harden
Journal:  J Natl Med Assoc       Date:  1974-09       Impact factor: 1.798

4.  Clinical interpretation of bilateral hilar adenopathy.

Authors:  R H Winterbauer; N Belic; K D Moores
Journal:  Ann Intern Med       Date:  1973-01       Impact factor: 25.391

5.  Sarcoidosis in Washington, D. C. Clinical observations in 105 black patients.

Authors:  R C Young; P Y Titus-Dillon; M L Schneider; T G Shelton; R L Hackney; K A Harden
Journal:  Arch Intern Med       Date:  1970-01

6.  The definitive evaluation of sarcoidosis.

Authors:  D C Kent; V N Houk; R C Elliott; J W Sokolowski; J H Baker; K Sorensen
Journal:  Am Rev Respir Dis       Date:  1970-05

7.  Pulmonary sarcoidosis: comparison of patients at a university and a municipal hospital.

Authors:  H Yeager; D L Rabin; S R Stein; M S Richardson; R Singh; M A Devine; M Freedman
Journal:  J Natl Med Assoc       Date:  1999-06       Impact factor: 1.798

8.  Smoking and interstitial lung disease. The effect of cigarette smoking on the incidence of pulmonary histiocytosis X and sarcoidosis.

Authors:  A J Hance; F Basset; G Saumon; C Danel; D Valeyre; J P Battesti; J Chrétien; R Georges
Journal:  Ann N Y Acad Sci       Date:  1986       Impact factor: 5.691

9.  Chronic airways obstruction in pulmonary sarcoidosis: its poor response to bronchodilators.

Authors:  R C Young; G K Sahetya; S N Hassan; W B Cobb; B Kumar; H T Facen
Journal:  J Natl Med Assoc       Date:  1980-10       Impact factor: 1.798
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.